Koligo Therapeutics (ASX:KOL) Accounts Payable: A$0.00 Mil (As of . 20)


What is Koligo Therapeutics Accounts Payable?

Koligo Therapeutics ASX:KOL Accounts Payable is A$0.00 Mil as of . 20.

Koligo Therapeutics's Accounts Payable for the quarter that ended in . 20 was A$0.00 Mil.

Koligo Therapeutics Accounts Payable Related Terms

Koligo Therapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Koligo Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koligo Therapeutics Accounts Payable Chart

Koligo Therapeutics Annual Data
Trend
Accounts Payable

Koligo Therapeutics Semi-Annual Data
Accounts Payable

Koligo Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of A$0.00 Mil mean?
Koligo Therapeutics (ASX:KOL) has a Accounts Payable of A$0.00 Mil as of . 20. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Koligo Therapeutics and its competitors.
Is Koligo Therapeutics' Accounts Payable too high?
Koligo Therapeutics' current Accounts Payable is A$0.00 Mil.
How does Koligo Therapeutics' Accounts Payable compare to ?
Koligo Therapeutics' Accounts Payable of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Koligo Therapeutics and its competitors. Koligo Therapeutics's current Accounts Payable is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koligo Therapeutics stock overvalued right now?
Koligo Therapeutics (ASX:KOL) has a current Accounts Payable of A$0.00 Mil. The current Accounts Payable is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Koligo Therapeutics (ASX:KOL), the current Accounts Payable is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Koligo Therapeutics Business Description

Comparable Companies